Other Clinical Trial - QLB Versus PVB for Acute Pain & Quality of Recovery

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This trial is a prospective, randomized, single-center, open-label, parallel-arm, blinded-analysis trial, the objective of which is to evaluate the effect of transmuscular quadratus lumborum block (TMQLB) in the pain relief and quality of recovery in laparoscopic partial nephrectomy compared with thoracic paravertebral block (TPVB).

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT03414281` - TMQLB Versus TPVB for Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery	N/A

NCT number	NCT03975296
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact
Status	Completed
Phase	N/A
Start date	June 10, 2019
Completion date	January 11, 2021

QLB Versus PVB for Acute Pain and Quality of Recovery After Laparoscopic Partial Nephrectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms